1-8 of 8
apixaban
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanisms

Annette von Drygalski, Vikas Bhat, Andrew J. Gale, Patricia M. Averell, Thomas J. Cramer, Darlene J. Elias, John H. Griffin, Laurent O. Mosnier
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3716–3727.
https://doi.org/10.1182/bloodadvances.2020001699
Published: 2020
Includes: Supplemental data
Journal Articles

Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure

Clinical Trials & Observations
Joseph R. Shaw, Na Li, Thomas Vanassche, Michiel Coppens, Alex C. Spyropoulos, Summer Syed, Mansoor Radwi, Joanne Duncan, Sam Schulman, James D. Douketis
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3520–3527.
https://doi.org/10.1182/bloodadvances.2020002335
Published: 2020
Includes: Supplemental data
Journal Articles

Outcomes associated with apixaban vs warfarin in patients with renal dysfunction

Clinical Trials & Observations
Claudia Hanni, Elizabeth Petrovitch, Mona Ali, Whitney Gibson, Christopher Giuliano, Jenna Holzhausen, Charles Makowski, Amy Pallisco, Nisha Patel, Denise Sutter, Long To, Raymond Yost
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2366–2371.
https://doi.org/10.1182/bloodadvances.2019000972
Published: 2020
Journal Articles

Bleeding and recurrent VTE with apixaban vs warfarin as outpatient treatment: time-course and subgroup analyses

Derek Weycker, Gail DeVecchis Wygant, Jennifer D. Guo, Theodore Lee, Xuemei Luo, Lisa Rosenblatt, Jack Mardekian, Mark Atwood, Ahuva Hanau, Alexander T. Cohen
Journal: Blood Advances
Blood Adv (2020) 4 (2): 432–439.
https://doi.org/10.1182/bloodadvances.2019001081
Published: 2020
Includes: Supplemental data
Journal Articles

Systematic review and meta-analysis of the efficacy and safety of apixaban compared to rivaroxaban in acute VTE in the real world

Madan Raj Aryal, Rohit Gosain, Anthony Donato, Han Yu, Anjan Katel, Yashoda Bhandari, Rashmi Dhital, Peter A. Kouides
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2381–2387.
https://doi.org/10.1182/bloodadvances.2019000572
Published: 2019
Includes: Supplemental data
Journal Articles

Model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients

Clinical Trials & Observations
Hideki Yoshioka, Hiromi Sato, Hiroto Hatakeyama, Akihiro Hisaka
Journal: Blood Advances
Blood Adv (2018) 2 (10): 1066–1075.
https://doi.org/10.1182/bloodadvances.2017013805
Published: 2018
Includes: Supplemental data
Journal Articles

Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation

Clinical Trials & Observations
Surbhi Shah, Faye L. Norby, Yvonne H. Datta, Pamela L. Lutsey, Richard F. MacLehose, Lin Y. Chen, Alvaro Alonso
Journal: Blood Advances
Blood Adv (2018) 2 (3): 200–209.
https://doi.org/10.1182/bloodadvances.2017010694
Published: 2018
Includes: Supplemental data
Journal Articles

Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa

Deborah Siegal, Genmin Lu, Janet M. Leeds, Mark Karbarz, Janice Castillo, Vandana Mathur, Athiwat Hutchaleelaha, Uma Sinha, Michael Kitt, Matt McClure, Stanley J. Hollenbach, John T. Curnutte, Pamela B. Conley, Mark Crowther
Journal: Blood Advances
Blood Adv (2017) 1 (21): 1827–1838.
https://doi.org/10.1182/bloodadvances.2017007112
Published: 2017
Includes: Supplemental data